Research Projects

SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma, a rare hematologic disease (CARAMBA)

Imagen del Dr. Jesús San Miguel Izquierdo, especialista en Hematología de la Clínica Universidad de Navarra. El Dr. San Miguel se dedica preferencialmente al mieloma múltiple.
Dr. Jesús San Miguel Curriculum
Senior Researcher | Principal Investigator Adoptive Cellular Therapy Research Group
Research program
Hemato-Oncology
Research group
Adoptive Cell Therapy. Hemato-oncology
Disease
Multiple myeloma

Project information

CARAMBA will be the first clinical trial targeting the myeloma-specific protein SLAMF7. The project's mission is to better understand the role of CAR-T therapy in myeloma and to explore sustainable regulatory and funding approaches so that healthcare systems can ensure patient access to this type of innovation.

  • Convocation: 2018-2022
  • Reference: 754658
  • Start date: January 1, 2018
  • End date: April 30, 2022
  • Funder: Comisión Europea
  • Grant: € 6 097 875
  • Nature of project: International
  • Award year 2017
More information about the project

Need more information?

If you are interested in learning more about our research, please contact us.